Showing results (311-320 of 436) with videos related to
Sort By:
Pageof 44
Biochemical and Biophysical Research Communications|February 15, 2011
Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemiasCui-Hua Ma, Jing-Hui Chong, Ye Guo, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|September 4, 2013
[Retrospective analysis of treatment strategy and prognosis in childhood myelodysplastic syndromes from China and Japan]Xiao-Juan Chen, Atsushi Manabe, Wen-Yu Yang, et al.Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 15, 2014
[Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia]Fang Liu, Yang Wan, Lixian Chang, et al.Analytical Chemistry|April 10, 2024
Well-Paired-Seq2: High-Throughput and High-Sensitivity Strategy for Characterizing Low RNA-Content Cell/Nucleus TranscriptomesKun Yin, Meijuan Zhao, Yiling Xu, et al.Therapeutic Advances in Medical Oncology|September 5, 2022
Efficacy and safety of selpercatinib in Chinese patients with advanced <i>RET</i>-altered thyroid cancers: results from the phase II LIBRETTO-321 studyXiangqian Zheng, Qinghai Ji, Yuping Sun, et al.Medicine|October 22, 2021
Smoking is a risk factor for postoperative ileus after radical resection in male patientsJiangling Wang, Wenjing Guo, Xiaoying Cui, et al.Asian Journal of Andrology|April 8, 2025
Integrated seminal plasma metabolomics and lipidomics profiling highlight distinctive signature of varicocele patients with male infertilityJing-Di Zhang, Xiao-Gang Li, Rong-Rong Wang, et al.Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|September 12, 2019
[Long-term clinical effect of the CCLG-ALL2008 regimen in treatment of childhood acute lymphoblastic leukemia with different molecular biological features]Xiao-Juan Chen, Yao Zou, Xiao-Ming Liu, et al.Journal of Cachexia, Sarcopenia and Muscle|July 20, 2024
Long-term insulin resistance is associated with frailty, frailty progression, and cardiovascular diseaseZezhi Ke, Han Wen, Rihua Huang, et al.Thoracic Cancer|December 1, 2021
Clinical outcome, long-term survival and tolerability of sequential therapy of first-line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in ChinaZihua Zou, Xuezhi Hao, Cuiying Zhang, et al.Pageof 44